XML 38 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY AND STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Sep. 30, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
NonVested Restricted Common Stock
 
Shares
 
Weighted
Average
Grant
Fair
Value
Balance, December 31, 2016
3,007,674

 
$
3.21

Granted
120,000

 
3.44

Forfeited
(98,800
)
 
3.17

Vested
(60,000
)
 
1.70

Balance, September 30, 2017
2,968,874

 
$
3.26

Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and nine months ended September 30, 2017 and September 24, 2016 (no tax benefits were recognized):
 
Three Months Ended
 
Nine Months Ended
 
September 30, 2017
 
September 24, 2016
 
September 30, 2017
 
September 24, 2016
Cost of product revenues
$
142,604

 
$
136,420

 
$
405,778

 
$
426,357

Research and development
203,288

 
129,308

 
616,500

 
378,156

Selling, general and administrative
676,137

 
262,700

 
1,967,879

 
674,968

Total
$
1,022,029

 
$
528,428

 
$
2,990,157

 
$
1,479,481